Hongo Killer
- Manufacturer
- Efficient Laboratories Inc | Dextrum Laboratories Inc.
- Effective date
- 2021-12-02
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 5
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 22:24:58
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active Ingredients: Purpose
Undelcylenic Acid 11% v/v ........................ Antifungal
OTC - PURPOSE SECTION
Uses
For effective treatment of athlete's foot (tinea pedis)
For the relief of itching, burning feet.
Clinically proven to preven Athlete's foot with daily use.
WARNINGS SECTION
Warnings
For external use only
Flammable: Keep away from fire and flame.
OTC - DO NOT USE SECTION
Do not use on children under 2 years of age, on diaper rash. This product is not effective on scalp or nails.
When using this product avoid contact with the eye and mucous membrane.
Stop use and ask doctor if irriation occurs, othere's no improvement within 4 weeks.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.If swallowed, get medical help or contact a Poison Control Center right away. If pregnant or breast feeding consult a health care professional before using this product.
DOSAGE & ADMINISTRATION SECTION
Directions
- clean the affected area with soap and water, dry thoroughly
- apply a thin layer of Hongo Killer over the affected area twice daily (morning and night) or as directed by a doctor
- for athlete's foot, pay special attention to spaces between the toes. Wear well-fitting, ventilated shoes and change shoes and socks at least once daily.
- Supervise children in the use of this product
INDICATIONS & USAGE SECTION
Other information store at room temperature 15°- 30°C (59° - 86°F). Do accept if safety seal is broken or missing. Also Hongo Killer is available in Spray, Cream, Powder, Spray Powder and Nail Formula.
Keep box for directions
OTC - QUESTIONS SECTION
INACTIVE INGREDIENT SECTION
Inactive ingredients Alcohol Isopropyl, Propionic Acid, Purified Water, Salicylic Acid and Sodium Propionate
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 58593-825-01 | 2021-02-11 | C162847 | 48780-1 | 960f7f55-d103-8e05-e053-dbdaa90a074a | Drug Facts |
| 58593-825-01 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-d103-8e05-e053-dbdaa90a074a | Drug Facts |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| UNDECYLENIC ACID | ACTIVE INGREDIENT | K3D86KJ24N | 3 | |
| UNDECYLENIC ACID | ACTIVE MOIETY | K3D86KJ24N | 3 | |
| ISOPROPYL ALCOHOL | INACTIVE INGREDIENT | ND2M416302 | 3 | |
| PROPIONIC ACID | INACTIVE INGREDIENT | JHU490RVYR | 3 | |
| SALICYLIC ACID | INACTIVE INGREDIENT | O414PZ4LPZ | 3 | |
| SODIUM PROPIONATE | INACTIVE INGREDIENT | DK6Y9P42IN | 3 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 3 |
Products#
Every source-derived product name is available through these pages.
- Hongo Killer
- Undecylenic Acid
- ISOPROPYL ALCOHOL
- PROPIONIC ACID
- WATER
- SALICYLIC ACID
- SODIUM PROPIONATE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 58593-825 | 58593-825-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ISOPROPYL ALCOHOL | ND2M416302 | IACT |
| PROPIONIC ACID | JHU490RVYR | IACT |
| WATER | 059QF0KO0R | IACT |
| SALICYLIC ACID | O414PZ4LPZ | IACT |
| SODIUM PROPIONATE | DK6Y9P42IN | IACT |
| UNDECYLENIC ACID | K3D86KJ24N | ACTIB |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| SODIUM PROPIONATE | SODIUM PROPIONATE | DK6Y9P42IN | SYRUP / ORAL | 40 mg | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | GEL, METERED / TOPICAL | 525 mg | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | TABLET, EXTENDED RELEASE / ORAL | NA | ||
| SODIUM PROPIONATE | SODIUM PROPIONATE | DK6Y9P42IN | SUSPENSION / ORAL | NA | ||
| SODIUM PROPIONATE | SODIUM PROPIONATE | DK6Y9P42IN | CAPSULE / ORAL | NA | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | LOTION, AUGMENTED / TOPICAL | 2070 mg | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | OIL / AURICULAR (OTIC) | 6 mg | ||
| SODIUM PROPIONATE | SODIUM PROPIONATE | DK6Y9P42IN | SOLUTION / ORAL | 80 mg | ||
| SODIUM PROPIONATE | SODIUM PROPIONATE | DK6Y9P42IN | CAPSULE, EXTENDED RELEASE / ORAL | NA | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | SWAB / TOPICAL | 43.9 %w/w | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | GEL / TOPICAL | 75 mg | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | SPONGE / TOPICAL | 4 %w/w | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | SOLUTION / TOPICAL | 40 %w/v | ||
| SODIUM PROPIONATE | SODIUM PROPIONATE | DK6Y9P42IN | POWDER, FOR SUSPENSION / ORAL | 12.5 mg/5ml | ||
| ISOPROPYL ALCOHOL | ISOPROPYL ALCOHOL | ND2M416302 | OIL / TOPICAL | 72 mg | ||
| SODIUM PROPIONATE | SODIUM PROPIONATE | DK6Y9P42IN | POWDER, FOR SOLUTION / ORAL | NA | ||
| PROPIONIC ACID | PROPIONIC ACID | JHU490RVYR | OINTMENT / TOPICAL | 2.7 %w/w |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| fbd3070a-afab-deb7-e053-6294a90acc7d | 7d26338a-3313-4e6a-83de-9d028770dcbf | 2023-05-16 | Warnings | 7d26338a-3313-4e6a-83de-9d028770dcbf |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
